| 
             【结 构 式】  
           | 
          
             【分子编号】42146 【品名】tert-butyl (1S)-5-[(tert-butoxycarbonyl)amino]-1-formylpentylcarbamate 【CA登记号】  | 
          
             【 分 子 式 】C16H30N2O5 【 分 子 量 】330.42468 【元素组成】C 58.16% H 9.15% N 8.48% O 24.21%  | 
        
与该中间体有关的原料药合成路线共 1 条
    合成路线1
该中间体在本合成路线中的序号:(XXIII)Simultaneous coupling of five N-Boc-arginin (XIX) residues to the free amino groups of the peptide template (XVIII), followed by acid deprotection of the Boc groups, furnished (XX). To this were assembled five N-Boc-proline residues (XXI) to provide, after acid deprotection, resin (XXII). Then, reductive condensation with Boc-protected lysinal (XXIII) furnished the protected pseudopeptide adduct (XXIV). Finally, simultaneous cleavage from the resin and removal of protecting groups was effected by treatment with anhydrous hydrogen fluoride.

| 【1】 Callebaut, C.; et al.; Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. Virology 1996, 218, 1, 181. | 
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 | 
|---|---|---|---|---|---|---|
| (XVIII) | 42143 | (3S,6S,9R,15R)-3,9-bis(4-aminobutyl)-1-[(2S)-1-((5S,8S)-5-(4-aminobutyl)-16-(4-chlorophenyl)-8-[[(2S)-2,6-diaminohexanoyl]amino]-4,7,14-trioxo-15-oxa-3,6,13-triazahexadec-1-anoyl)pyrrolidinyl]-6-[3-(cyclohexyloxy)-3-oxopropyl]-15-[[(4-methylbenzyl)s | C70H111ClN14O15S | 详情 | 详情 | |
| (XIX) | 14073 | (2S)-5-[[Amino(imino)methyl]amino]-2-[(tert-butoxycarbonyl)amino]pentanoic acid | 13726-76-6 | C11H22N4O4 | 详情 | 详情 | 
| (XX) | 42144 | C100H171ClN34O24S | 详情 | 详情 | ||
| (XXI) | 16734 | (2S)-1-(tert-butoxycarbonyl)tetrahydro-1H-pyrrole-2-carboxylic acid; N-alpha-t-BOC-L-proline; (2S)-1-(tert-butoxycarbonyl)-2-pyrrolidinecarboxylic acid | C10H17NO4 | 详情 | 详情 | |
| (XXII) | 42145 | C81H126ClN19O17SArg4Pro4 | 详情 | 详情 | ||
| (XXIII) | 42146 | tert-butyl (1S)-5-[(tert-butoxycarbonyl)amino]-1-formylpentylcarbamate | C16H30N2O5 | 详情 | 详情 | |
| (XXIV) | 42147 | C205H350ClN53O50S | 详情 | 详情 | 
     Extended Information